Kewaunee Scientific Stock EBITDA
KEQU Stock | USD 41.73 0.96 2.25% |
Kewaunee Scientific fundamentals help investors to digest information that contributes to Kewaunee Scientific's financial success or failures. It also enables traders to predict the movement of Kewaunee Stock. The fundamental analysis module provides a way to measure Kewaunee Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kewaunee Scientific stock.
Last Reported | Projected for Next Year | ||
EBITDA | 18 M | 18.9 M |
Kewaunee | EBITDA |
Kewaunee Scientific Company EBITDA Analysis
Kewaunee Scientific's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Kewaunee Scientific EBITDA | 18.04 M |
Most of Kewaunee Scientific's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kewaunee Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Kewaunee EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Kewaunee Scientific is extremely important. It helps to project a fair market value of Kewaunee Stock properly, considering its historical fundamentals such as EBITDA. Since Kewaunee Scientific's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kewaunee Scientific's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kewaunee Scientific's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
Kewaunee Ebitda
Ebitda |
|
According to the company disclosure, Kewaunee Scientific reported earnings before interest,tax, depreciation and amortization of 18.04 M. This is 98.24% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 99.54% higher than that of the company.
Kewaunee EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kewaunee Scientific's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kewaunee Scientific could also be used in its relative valuation, which is a method of valuing Kewaunee Scientific by comparing valuation metrics of similar companies.Kewaunee Scientific is currently under evaluation in ebitda category among its peers.
Kewaunee Scientific ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Kewaunee Scientific's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Kewaunee Scientific's managers, analysts, and investors.Environmental | Governance | Social |
Kewaunee Scientific Institutional Holders
Institutional Holdings refers to the ownership stake in Kewaunee Scientific that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Kewaunee Scientific's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Kewaunee Scientific's value.Shares | Comprehensive Portfolio Management, Llc | 2024-09-30 | 10.9 K | Citadel Advisors Llc | 2024-09-30 | 6.5 K | Citigroup Inc | 2024-09-30 | 6.4 K | Royal Bank Of Canada | 2024-06-30 | 2.5 K | Lsv Asset Management | 2024-09-30 | 2.3 K | Ubs Group Ag | 2024-06-30 | 885 | U.s. Bancorp | 2024-06-30 | 500 | Redwood Wealth Management Group Llc | 2024-06-30 | 500 | Advisor Group Holdings, Inc. | 2024-06-30 | 175 | Northern Trust Corp | 2024-09-30 | 287.8 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 186.9 K |
Kewaunee Fundamentals
Return On Equity | 0.38 | ||||
Return On Asset | 0.0628 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.05 % | ||||
Current Valuation | 106.73 M | ||||
Shares Outstanding | 2.87 M | ||||
Shares Owned By Insiders | 25.43 % | ||||
Shares Owned By Institutions | 38.90 % | ||||
Number Of Shares Shorted | 40.17 K | ||||
Price To Earning | 86.02 X | ||||
Price To Book | 2.14 X | ||||
Price To Sales | 0.61 X | ||||
Revenue | 203.75 M | ||||
Gross Profit | 35.59 M | ||||
EBITDA | 18.04 M | ||||
Net Income | 18.75 M | ||||
Cash And Equivalents | 14.36 M | ||||
Cash Per Share | 5.07 X | ||||
Total Debt | 11 M | ||||
Debt To Equity | 1.09 % | ||||
Current Ratio | 1.98 X | ||||
Book Value Per Share | 19.51 X | ||||
Cash Flow From Operations | 19.56 M | ||||
Short Ratio | 3.34 X | ||||
Earnings Per Share | 6.26 X | ||||
Target Price | 28.0 | ||||
Number Of Employees | 1.01 K | ||||
Beta | 0.74 | ||||
Market Capitalization | 122.28 M | ||||
Total Asset | 134.77 M | ||||
Retained Earnings | 47.51 M | ||||
Working Capital | 56.04 M | ||||
Current Asset | 50.96 M | ||||
Current Liabilities | 20.95 M | ||||
Five Year Return | 2.95 % | ||||
Net Asset | 134.77 M |
About Kewaunee Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kewaunee Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kewaunee Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kewaunee Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kewaunee Stock Analysis
When running Kewaunee Scientific's price analysis, check to measure Kewaunee Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kewaunee Scientific is operating at the current time. Most of Kewaunee Scientific's value examination focuses on studying past and present price action to predict the probability of Kewaunee Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kewaunee Scientific's price. Additionally, you may evaluate how the addition of Kewaunee Scientific to your portfolios can decrease your overall portfolio volatility.